Recent developments in the management of acute respiratory distress syndrome in adults

American Journal of Health-System Pharmacy

Volumn 65, Issue 1, 2008, Pages 29-36

  Bream Rouwenhorst, Heather R ^a,b   Beltz, Elizabeth A ^b,c   Ross, Mary B ^b,c   Moores, Kevin G ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UIHC

Author keywords

Acetylcysteine; Albuterol; Gases; Mortality; Mucolytic agents; Nitric oxide; Prostaglandins; Pulmonary surfactants; Respiratory distress syndrome; Steroids, cortico ; Sympathomimetic agents; Toxicity

Indexed keywords

ACETYLCYSTEINE; ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HYDROCORTISONE; METHYLPREDNISOLONE; MUCOLYTIC AGENT; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E1; SALBUTAMOL; SURFACTANT;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ARTIFICIAL VENTILATION; BODY POSTURE; CONSERVATIVE TREATMENT; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; INFECTION; INTENSIVE CARE; LOW DRUG DOSE; MORBIDITY; MORTALITY; PATIENT CARE; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY INFECTION; SHORT COURSE THERAPY; STANDARD; TIDAL VOLUME; VENTILATOR;

EID: 37848999396     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060530     Document Type: Review

References (37)

1. Bernard G, Artigas A, Carlet J et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149:818-24.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000; 342:1334-49.
3. Levy BD, Shapiro SD. Acute respiratory distress syndrome. In: Kasper DL, Braunwald E, Fauci AS et al., eds. Harrison's internal medicine. 16th ed. New York: McGraw-Hill; 2005:1592-5.
4. Rubenfeld GD, Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353:1685-93.
5. Cronin L, Cook DJ, Carlet J et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995; 23:1430-9.
6. Bone RC, Fisher CJ, Clemmer TP et al. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987; 92:1032-6.
7. Steinberg KP, Hudson LD, Goodman RB et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006; 354:1671-84.
8. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med. 1995; 23:1294-303.
9. Bernard GR, Luce JM, Sprung CL et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987; 317:1565-70.
10. Meduri GU, Headley AS, Golden E et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. JAMA. 1998; 280:159-65.
11. Meduri GU, Golden E, Freire AX et al. Methylprednisolone infusion in patients with early acute respiratory distress syndrome (ARDS) significantly improves lung function: results of a randomized controlled trial (RCT). Chest. 2005; 128:S129-30. Abstract.
12. Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment. Arch Surg. 1985; 120:530-5.
13. Hooper RG, Kearl RA. Established ARDS treated with a sustained course of adrenocortical steroids. Chest. 1990; 97:138-43.
14. Hooper RG, Kearl RA. Established adult respiratory distress syndrome successfully treated with corticosteroids. South Med J. 1996; 89:359-64.
15. Biffl WL, Moore FA, Moore EE et al. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am J Surg. 1995; 170:591-5.
16. Keel JB, Hauser M, Stocker R et al. Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy. Respiration. 1998; 65:258-64.
17. Meduri GU, Belenchia JM, Estes RJ et al. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991; 100:943-52.
18. Meduri GU, Chinn AJ, Leeper KV et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest. 1994; 105:1516-27.
19. Meduri GU, Headley S, Tolley E et al. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest. 1995; 108:1315-25.
20. Brower RG, Matthay MA, Morris A et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342:1301-8.
21. Wiedemann HP, Wheeler AP, Bernard GR et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354:2564-75.
22. Brower RG, Lanken PN, MacIntyre N et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004; 351:327-36.
23. Kallet RH, Jasmer RM, Pittet JF et al. Clinical implementation of the ARDS network protocol is associated with reduced hospital mortality compared with historical controls. Crit Care Med. 2005; 33:925-9.
24. Amato MB, Barbas CS, Medeiros DM et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998; 338:347-54.
25. Taylor RW, Zimmerman JL, Dellinger RP et al. Low-dose inhaled nitric oxide in patients with acute lung injury. JAMA. 2004; 291:1603-9.
26. Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005; 353:2683-95.
27. Davidson WJ, Dorscheid D, Spragg R et al. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care. 2006; 10:R41-9.
28. Camamo JM, McCoy RH, Erstad BL. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome. Pharmacotherapy. 2005; 25:184-90.
29. Van Heerden PV, Barden A, Michalopoulos N et al. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest. 2000; 117:819-27.
30. Vincent JL, Brase R, Santman F et al. A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome. Intensive Care Med. 2001; 27:1578-83.
31. Pesenti A, Pelosi P, Rossi N et al. Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome. Crit Care Med. 1993; 21:78-83.
32. Morina P, Herrera M, Venegas J et al. Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med. 1997; 23:58-64.
33. Perkins GD, McAuley DF, Thickett DR et al. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med. 2006; 173:281-7.
34. Domenighetti G, Suter PM, Schaller MD et al. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care. 1997; 12:177-82.
35. Bernard GR, Wheeler AP, Arons MM et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. Chest. 1997; 112:164-72.
36. Guerin C, Gaillard S, Lemasson S et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004; 292:2379-87.
37. Gattinoni L, Tognoni G, Pesenti A et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001; 345:568-73.